ArticleJournal of cancer research and clinical oncology2023

Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC.

Anushka Walia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.